Phe-Lys(Trt)-PAB is a dipeptide-based ADC linker designed for payload release in antibody-drug conjugates. The PAB spacer ensures efficient cleavage, while the Trt group protects during synthesis. Suitable for designing stable and effective ADCs in preclinical and clinical research.
Structure of 1116085-99-4
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00709 | Fmoc-Phe-Lys(Trt)-PAB | 1116085-98-3 | |
BADC-00495 | Fmoc-Phe-Lys(Trt)-PAB-PNP | 1116086-09-9 | |
BADC-00980 | Fmoc-Phe-Lys(Boc)-PAB-PNP | 1646299-50-4 | |
BADC-01529 | (Ac)Phe-Lys(Alloc)-PABC-PNP | 2070009-39-9 | |
BADC-00370 | Phe-Lys(Fmoc)-PAB | 2149584-03-0 | |
BADC-00492 | Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP | 253863-34-2 | |
BADC-01427 | EMCC-PEG8-Phe-Lys-PNP | ||
BADC-01475 | N3-PEG8-Phe-Lys-PABC-Gefitinib |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.